Approval · Notice of Compliance 8918 · 2007
LOPRESOR: Notice of Compliance 8918
Issued July 19, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8918
- Date
- July 19, 2007
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication to include long-term treatment of angina pectoris due to ischemic heart disease and other revisions to the product monograph
- Therapeutic class
- B-adrenergic receptor blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOPRESOR | Not yet assigned | — |
| LOPRESOR SR | Not yet assigned | — |
Medicinal ingredients
- METOPROLOL TARTRATE 50 MG per TAB
- METOPROLOL TARTRATE 100 MG per TAB
- METOPROLOL TARTRATE 200 MG per TAB
- METOPROLOL TARTRATE 1 MG per AMP